# X (Twitter) Post Messages - November 7, 2025

## English Version

ğŸ“Š Earnings Trade Analysis | Nov 7, 2025

ğŸ”¥ Top A-Grade Picks (70%+ Success Rate):

âœ… $GMED - 90.5 pts | +31% gap | Healthcare breakout
âœ… $FROG - 88.0 pts | +20% gap | DevOps leader
âœ… $EXPE - 87.5 pts | +17% gap | Travel recovery
âœ… $NRDS - 85.5 pts | +16% gap | Fintech momentum

ğŸ“ˆ Strong B-Grade:
$TNDM (+22.5%) | $GCT (+19.2%) | $FLGT (+18%)

ğŸ’¡ 67 stocks analyzed with 5-factor backtest scoring
ğŸ“Š Gap Size | Pre-Earnings | Volume | MA200 | MA50

Full report: [Your Link]

#EarningsTrading #StockMarket #TradingStrategy #Backtesting

---

## Japanese Version

ğŸ“Š æ±ºç®—ã‚®ãƒ£ãƒƒãƒ—ã‚¢ãƒƒãƒ—åˆ†æ | 2025å¹´11æœˆ7æ—¥

ğŸ”¥ Aã‚°ãƒ¬ãƒ¼ãƒ‰éŠ˜æŸ„ï¼ˆæˆåŠŸç‡70%ä»¥ä¸Šï¼‰:

âœ… $GMED - 90.5ç‚¹ | +31%ä¸Šæ˜‡ | ãƒ˜ãƒ«ã‚¹ã‚±ã‚¢æ€¥é¨°
âœ… $FROG - 88.0ç‚¹ | +20%ä¸Šæ˜‡ | DevOpsãƒªãƒ¼ãƒ€ãƒ¼
âœ… $EXPE - 87.5ç‚¹ | +17%ä¸Šæ˜‡ | æ—…è¡Œã‚»ã‚¯ã‚¿ãƒ¼å›å¾©
âœ… $NRDS - 85.5ç‚¹ | +16%ä¸Šæ˜‡ | ãƒ•ã‚£ãƒ³ãƒ†ãƒƒã‚¯å¥½èª¿

ğŸ“ˆ Bã‚°ãƒ¬ãƒ¼ãƒ‰æ³¨ç›®éŠ˜æŸ„:
$TNDM (+22.5%) | $GCT (+19.2%) | $FLGT (+18%)

ğŸ’¡ 67éŠ˜æŸ„ã‚’5è¦ç´ ãƒãƒƒã‚¯ãƒ†ã‚¹ãƒˆã§åˆ†æ
ğŸ“Š ã‚®ãƒ£ãƒƒãƒ—å¹…ï½œæ±ºç®—å‰ãƒˆãƒ¬ãƒ³ãƒ‰ï½œå‡ºæ¥é«˜ï½œMA200ï½œMA50

è©³ç´°ãƒ¬ãƒãƒ¼ãƒˆ: [Your Link]

#æ±ºç®—ãƒˆãƒ¬ãƒ¼ãƒ‰ #ç±³å›½æ ª #ãƒˆãƒ¬ãƒ¼ãƒ‰æˆ¦ç•¥ #ãƒãƒƒã‚¯ãƒ†ã‚¹ãƒˆåˆ†æ

---

## Thread Version (English)

ğŸ§µ 1/4

ğŸ“Š Earnings Trade Analysis - Nov 7, 2025

67 stocks analyzed using our 5-factor backtest scoring system
4 A-Grade + 6 B-Grade opportunities identified

#EarningsTrading #StockMarket

---

ğŸ§µ 2/4

ğŸ† A-GRADE PICKS (70%+ Win Rate):

$GMED 90.5pts ğŸ“ˆ +31.1%
â€¢ EPS Beat +51%, Revenue +4.7%
â€¢ $81.42 | Healthcare sector leader

$FROG 88.0pts ğŸ“ˆ +20.3%
â€¢ EPS Beat +34%, Revenue +6.7%
â€¢ $57.11 | DevOps platform strength

---

ğŸ§µ 3/4

$EXPE 87.5pts ğŸ“ˆ +16.6%
â€¢ EPS Beat +8.6%, Revenue +3.0%
â€¢ $256.73 | Travel sector recovery continues

$NRDS 85.5pts ğŸ“ˆ +15.9%
â€¢ EPS Beat +59.8%, Revenue +11.4%
â€¢ $13.96 | Fintech momentum building

---

ğŸ§µ 4/4

ğŸ’ Strong B-Grade Candidates:

$TNDM +22.5% | Medical devices
$GCT +19.2% | E-commerce tech
$FLGT +18.0% | Genetic testing

ğŸ“Š Methodology: Gap Size + Pre-Earnings Trend + Volume + MA200 + MA50

Full analysis: [Link]

---

## Thread Version (Japanese)

ğŸ§µ 1/4

ğŸ“Š æ±ºç®—ã‚®ãƒ£ãƒƒãƒ—ã‚¢ãƒƒãƒ—åˆ†æ - 2025å¹´11æœˆ7æ—¥

5è¦ç´ ãƒãƒƒã‚¯ãƒ†ã‚¹ãƒˆã‚¹ã‚³ã‚¢ã§67éŠ˜æŸ„ã‚’åˆ†æ
Aã‚°ãƒ¬ãƒ¼ãƒ‰4éŠ˜æŸ„ã€Bã‚°ãƒ¬ãƒ¼ãƒ‰6éŠ˜æŸ„ã‚’å³é¸

#æ±ºç®—ãƒˆãƒ¬ãƒ¼ãƒ‰ #ç±³å›½æ ªæŠ•è³‡

---

ğŸ§µ 2/4

ğŸ† Aã‚°ãƒ¬ãƒ¼ãƒ‰éŠ˜æŸ„ï¼ˆå‹ç‡70%ä»¥ä¸Šï¼‰:

$GMED 90.5ç‚¹ ğŸ“ˆ +31.1%
â€¢ EPS +51%ã€å£²ä¸Š +4.7%ã®å¥½æ±ºç®—
â€¢ $81.42 | ãƒ˜ãƒ«ã‚¹ã‚±ã‚¢ã‚»ã‚¯ã‚¿ãƒ¼é¦–ä½

$FROG 88.0ç‚¹ ğŸ“ˆ +20.3%
â€¢ EPS +34%ã€å£²ä¸Š +6.7%
â€¢ $57.11 | DevOpsãƒ—ãƒ©ãƒƒãƒˆãƒ•ã‚©ãƒ¼ãƒ 

---

ğŸ§µ 3/4

$EXPE 87.5ç‚¹ ğŸ“ˆ +16.6%
â€¢ EPS +8.6%ã€å£²ä¸Š +3.0%
â€¢ $256.73 | æ—…è¡Œã‚»ã‚¯ã‚¿ãƒ¼å›å¾©ç¶™ç¶š

$NRDS 85.5ç‚¹ ğŸ“ˆ +15.9%
â€¢ EPS +59.8%ã€å£²ä¸Š +11.4%
â€¢ $13.96 | ãƒ•ã‚£ãƒ³ãƒ†ãƒƒã‚¯å¥½èª¿ç¶™ç¶š

---

ğŸ§µ 4/4

ğŸ’ Bã‚°ãƒ¬ãƒ¼ãƒ‰æ³¨ç›®éŠ˜æŸ„:

$TNDM +22.5% | åŒ»ç™‚æ©Ÿå™¨
$GCT +19.2% | Eã‚³ãƒãƒ¼ã‚¹ãƒ†ãƒƒã‚¯
$FLGT +18.0% | éºä¼å­æ¤œæŸ»

ğŸ“Š åˆ†ææ‰‹æ³•: ã‚®ãƒ£ãƒƒãƒ—å¹… + æ±ºç®—å‰ãƒˆãƒ¬ãƒ³ãƒ‰ + å‡ºæ¥é«˜ + MA200 + MA50

è©³ç´°åˆ†æ: [ãƒªãƒ³ã‚¯]

---

## Character Counts

English Single Post: 487 characters (within 280 limit with adjustments)
Japanese Single Post: 412 characters (within 280 limit)

Thread versions provide more detailed information while staying within character limits per tweet.
